The Glymphatic System: A Novel Component of Fundamental Neurobiology.
Lauren M Hablitz, Maiken Nedergaard
https://pubmed.ncbi.nlm.nih.gov/34526407/Actively Recruiting
Led by New York Institute of Technology · Updated on 2026-06-29
32
Participants Needed
1
Research Sites
N/A
Total Duration
Parkinsonism, primarily caused by Parkinsons disease PD, includes symptoms such as tremors, muscle stiffness, slow movements, and balance difficulties. These symptoms often disrupt sleep quality, leading to challenges falling and staying asleep. Poor sleep in PD patients can lower quality of life and increase risks of other health problems and cognitive decline. This study explores whether osteopathic manipulative treatment OMT, a hands-on therapy, can improve sleep quality, cognitive function, and daily activities in people with Parkinsons disease. Participants will be divided into two groups one receiving a specific OMT protocol targeting the cranial, cervical, thoracic, and ribcage areas using established techniques, and a control group receiving a light touch procedure. The OMT techniques include suboccipital decompression, venous sinus drainage, rib raising, and other manipulations aimed at improving circulation and relaxation. The control group receives light touch treatment to compare effects. During the 5-week study, participants will wear Fitbit devices and oxygen saturation rings to objectively track sleep patterns and oxygen levels, while also completing sleep quality surveys. Cognitive function will be assessed using the Stroop task to measure executive function. Researchers will analyze heart rate variability, sleep stages, sleep duration, and oxygen saturation to evaluate treatment effects. This research aims to determine if OMT can be a helpful complementary therapy for improving sleep and cognitive health in PD patients.
CONDITIONS
Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
S
Sheldon Yao, Doctor of Osteopathic Medicine
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
New York Institute of Technology
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | OMT Treatment | Sham Control |
|---|---|---|
| What is it? | Hands-on osteopathic manipulative treatment (OMT) involving manual techniques to cranial, cervical, thoracic, and ribcage regions, performed to address sleep disturbances in Parkinson's disease. | A light touch procedure applied in a similar setting and manner as OMT, but without the therapeutic manipulative techniques, serving as a control intervention. |
| Role in the trial | Investigational arm: assesses the effects of targeted OMT protocol on sleep quality and related measures for people with Parkinson's disease. | Comparator arm: assists in determining whether changes in sleep quality are specific to the OMT treatment rather than general effects of touch or participation. |
| Primary use | Being studied to see if OMT can improve sleep quality, duration, and related physiological parameters in people with Parkinson's disease. | Functions as a placebo-like control for evaluating the effects of the OMT protocol on sleep outcomes. |
| How it is given or performed | Participants undergo a series of OMT techniques directed at the head, neck, thorax, ribcage, and diaphragm in supine and prone positions. These include decompression, myofascial release, and lymphatic pump maneuvers. | Participants receive gentle light touch applied by the practitioner without targeted manipulative actions, simulating the attention and context of OMT sessions. |
| Evidence status | Ongoing clinical investigation; results for this trial arm are not yet established. Current published evidence for OMT's effect on sleep in Parkinson's is limited and under further study. | Serves as a control group; no therapeutic effect is anticipated from light touch control beyond possible placebo response. No effectiveness claims are made for this arm. |
| Important limitations | The trial has a small planned sample size and is limited to people with Parkinson's disease of mild to moderate severity (Hoehn and Yahr 0-3) who are not taking sleep-altering medications or diagnosed with other sleep or neurological disorders. | As the sham group mimics the experience of OMT without therapeutic maneuvers, any measured changes may reflect placebo or attention effects rather than treatment-specific benefit. Small sample and tight sleep-related exclusions may limit generalizability. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - 5 weeks
Participants receive either osteopathic manipulative treatment (OMT) targeting specific body regions or a light touch control procedure.
Regular visits during treatment period
Duration - 5 weeks
Participants' sleep quality, heart rate variability, oxygen saturation, and cognitive function are evaluated using surveys, Fitbit devices, oxygen rings, and the Stroop task.
Continuous monitoring during treatment
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Lauren M Hablitz, Maiken Nedergaard
https://pubmed.ncbi.nlm.nih.gov/34526407/New York Institute of Technology
Lead Sponsor